Humana Inc. (HUM) FCF Payout Ratio: 33.52%
Is Humana Inc.’s FCF payout ratio high or low?
Humana Inc.'s FCF payout ratio of 33.52% is in line with its 5-year average of 33.99%, near the low end of its 5-year range (6.91%–114.67%).
The FCF payout ratio for Humana Inc. (HUM) is 33.52%. It is below its 12-month average by 49.48% (66.35%).
HUM FCF Payout Ratio Chart
HUM Average FCF Payout Ratio Chart
HUM Current vs Average FCF Payout Ratio Chart
HUM FCF Payout Ratio Metrics
FCF PAYOUT RATIO
33.52%
FCF PAYOUT RATIO AVG TTM
66.35%
FCF PAYOUT RATIO AVG 3Y
39.63%
FCF PAYOUT RATIO AVG 5Y
33.99%
FCF PAYOUT RATIO AVG 10Y
26.90%
FCF PAYOUT RATIO AVG 15Y
22.70%
FCF PAYOUT RATIO AVG 20Y
22.70%
CURRENT VS TTM AVG
-49.48%
CURRENT VS 3Y AVG
-15.42%
CURRENT VS 5Y AVG
-1.37%
CURRENT VS 10Y AVG
+24.59%
CURRENT VS 15Y AVG
+47.67%
CURRENT VS 20Y AVG
+47.67%
Payout Ratio Comparison
FCF Payout Ratio
33.5%
Earnings Payout Ratio
35.9%
Dividend Yield
0.97%
FCF Yield
2.89%
Annual FCF Payout Ratio History
| Year | Free Cash Flow | Dividends Paid | FCF Payout Ratio |
|---|---|---|---|
| 2025 | $375.00M | $430.00M | 114.7% |
| 2024 | $2.39B | $431.00M | 18.0% |
| 2023 | $2.98B | $431.00M | 14.5% |
| 2022 | $3.45B | $392.00M | 11.4% |
| 2021 | $920.00M | $354.00M | 38.5% |
| 2020 | $4.67B | $323.00M | 6.9% |
| 2019 | $4.55B | $291.00M | 6.4% |
| 2018 | $1.56B | $265.00M | 17.0% |
| 2017 | $3.52B | $220.00M | 6.2% |
| 2016 | $1.41B | $177.00M | 12.6% |
| 2015 | $345.00M | $172.00M | 49.9% |
| 2014 | $1.09B | $172.00M | 15.8% |
| 2013 | $1.28B | $168.00M | 13.1% |
| 2012 | $1.51B | $165.00M | 10.9% |
| 2011 | $1.74B | $82.00M | 4.7% |
| 2010 | $2.02B | $0 | 0.0% |
| 2009 | $1.24B | $0 | 0.0% |
| 2008 | $720.74M | $0 | 0.0% |
| 2007 | $985.02M | $0 | 0.0% |
| 2006 | $1.49B | $0 | 0.0% |
| 2005 | $459.78M | $0 | 0.0% |
| 2004 | $233.71M | $0 | 0.0% |
| 2003 | $311.87M | $0 | 0.0% |
| 2002 | $209.27M | $0 | 0.0% |
| 2001 | $33.99M | $0 | 0.0% |
| 2000 | ($95.00M) | $0 | N/A (Loss) |
| 1999 | $128.00M | $0 | 0.0% |
| 1998 | ($28.00M) | $0 | N/A (Loss) |
| 1997 | $216.00M | $0 | 0.0% |
| 1996 | $269.00M | $0 | 0.0% |
Formula: FCF Payout Ratio = Dividends Paid / Free Cash Flow × 100
FCF payout and earnings payout:
- FCF represents operating cash flow after capital expenditures
- FCF payout compares dividends paid with free cash flow
- FCF payout above 100% means dividends paid exceeded free cash flow for the period
- Earnings payout compares dividends paid with net income
Reading the series: Use the chart and table to compare dividend payments with cash generation over time.
Humana Inc. FCF Payout Ratio Formula & Definition
FCF Payout Ratio measures what percentage of free cash flow is paid out as dividends. Unlike earnings-based payout, it compares dividends with cash generated after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Humana Inc. FCF Payout Ratio FAQ
- What is the FCF payout ratio for Humana Inc. (HUM)?
- The FCF payout ratio for HUM stock is 33.52%.
- Is Humana Inc.'s FCF payout ratio high or low?
- Humana Inc.'s FCF payout ratio of 33.52% is in line with its 5-year average of 33.99%, near the low end of its 5-year range (6.91%–114.67%).
- What is the TTM average FCF payout ratio for Humana Inc. (HUM)?
- The TTM average FCF payout ratio for HUM stock is 66.35%.
- What is the 3Y average FCF payout ratio for Humana Inc. (HUM)?
- The 3Y average FCF payout ratio for HUM stock is 39.63%.
- What is the 5Y average FCF payout ratio for Humana Inc. (HUM)?
- The 5Y average FCF payout ratio for HUM stock is 33.99%.
- What is the 10Y average FCF payout ratio for Humana Inc. (HUM)?
- The 10Y average FCF payout ratio for HUM stock is 26.90%.
- What is the 15Y average FCF payout ratio for Humana Inc. (HUM)?
- The 15Y average FCF payout ratio for HUM stock is 22.70%.
- What is the 20Y average FCF payout ratio for Humana Inc. (HUM)?
- The 20Y average FCF payout ratio for HUM stock is 22.70%.
Humana Inc. FCF Payout Ratio History
| DATE | FCF PAYOUT RATIO |
|---|---|
| 2025-12-31 | 114.67% |
| 2024-12-31 | 18.03% |
| 2023-12-31 | 14.48% |
| 2022-12-31 | 11.36% |
| 2021-12-31 | 38.48% |
| 2020-12-31 | 6.91% |
| 2019-12-31 | 6.40% |
| 2018-12-31 | 16.98% |
| 2017-12-31 | 6.24% |
| 2016-12-31 | 12.56% |
| 2015-12-31 | 49.86% |
| 2014-12-31 | 15.78% |
| 2013-12-31 | 13.14% |
| 2012-12-31 | 10.91% |
| 2011-12-31 | 4.70% |
About Humana Inc.
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- James A. Rechtin